Literature DB >> 21351579

[Dual effects of extract of Schisandra chinensis Baill on rat hepatic CYP3A].

Qian Chen1, Yu-jing Wu, Neng-neng Cheng, Ya-lin Li, Yong-ming Wang.   

Abstract

This study is to investigate the effects of aqueous extract of Schisandra chinensis Baill (WWZ), kadsurin, schisandrin A, schisandrin B and schisandrol B on rat hepatic CYP3A. Rats received a daily gavage of aqueous extract of WWZ for different times. The livers were harvested after gavage and subjected to microsome preparation. Microsomal CYP3A activity was determined by measuring the amount of the metabolite of testosterone (6 beta-hydroxytestosterone) with HPLC. Aqueous extract of WWZ, kadsurin and schisandrin A were incubated with microsomes obtained from rat. Microsomal CYP3A activity was determined by HPLC. Primary hepatocytes were separated and extracted from rat, then were treated with aqueous extract of WWZ, schisandrin A, schisandrin B and schisandrol B. Then, the expression of CYP3A1 mRNA was analyzed by RT-PCR. As for the in vivo assay, aqueous extract of WWZ significantly inhibited the enzyme activity of CYP3A after 12 h gavage. The inhibitory effect was converted to inductive effect after 3-day gavage. Aqueous extract of WWZ could induce the enzyme activity of CYP3A after 6-day gavage. Aqueous extract of WWZ and kadsurin showed a dose-dependent inhibition of CYP3A (IC50 of 487.8 microg mL(-1) and 6.2 micromol L(-1), separately). In rat primary hepatocytes, aqueous extract of WWZ (2.5 mg mL(-1)), schisandrin A (0.1 micromol L(-1)), schisandrin B (0.1 micromol L(-1)) and schisandrol B (10 micromol L(-1)) increased significantly the expression of CYP3A1 mRNA by 23%, 55%, 42% and 27%, respectively. Aqueous extract of WWZ could show dual effect on the enzyme activity of CYP3A in rat in vivo. Meanwhile, kadsurin showed a dose-dependent inhibition of the enzyme activity of hepatic CYP3A in vitro. And schisandrin A, schisandrin B and schisandrol B showed significant inductive effect on the expression of rat CYP3A1 mRNA.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21351579

Source DB:  PubMed          Journal:  Yao Xue Xue Bao        ISSN: 0513-4870


  6 in total

1.  Schisandra chinensis Baill, a Chinese medicinal herb, alleviates high-fat-diet-inducing non-alcoholic steatohepatitis in rats.

Authors:  Zheng Yao; Xiao-Chen Liu; Ying-Er Gu
Journal:  Afr J Tradit Complement Altern Med       Date:  2013-11-02

2.  A Network Pharmacology-Based Study on the Hepatoprotective Effect of Fructus Schisandrae.

Authors:  Ming Hong; Yongsheng Zhang; Sha Li; Hor Yue Tan; Ning Wang; Shuzhen Mu; Xiaojiang Hao; Yibin Feng
Journal:  Molecules       Date:  2017-09-28       Impact factor: 4.411

3.  Schisandrin B elicits the Keap1-Nrf2 defense system via carbene reactive metabolite which is less harmful to mice liver.

Authors:  Shan Feng; Bingxun Qiu; Li Zou; Ke Liu; Xiaoyu Xu; Huifeng Zhu
Journal:  Drug Des Devel Ther       Date:  2018-11-23       Impact factor: 4.162

Review 4.  Overcoming P-Glycoprotein-Mediated Multidrug Resistance in Colorectal Cancer: Potential Reversal Agents among Herbal Medicines.

Authors:  Gayoung Lee; Jin-Yong Joung; Jung-Hyo Cho; Chang-Gue Son; Namhun Lee
Journal:  Evid Based Complement Alternat Med       Date:  2018-08-12       Impact factor: 2.629

Review 5.  A Comprehensive Review of the Main Lignan Components of Schisandra chinensis (North Wu Wei Zi) and Schisandra sphenanthera (South Wu Wei Zi) and the Lignan-Induced Drug-Drug Interactions Based on the Inhibition of Cytochrome P450 and P-Glycoprotein Activities.

Authors:  Feng Zhang; Jianxiu Zhai; Nan Weng; Jie Gao; Jun Yin; Wansheng Chen
Journal:  Front Pharmacol       Date:  2022-03-11       Impact factor: 5.810

6.  Combination Therapy of Wuweizi (Schisandrae Chinensis Fructus) and Dexamethasone Alleviated Dexamethasone-Induced Glucocorticoid Osteoporosis in Rats with Idiopathic Pulmonary Fibrosis.

Authors:  Zinan Qin; Siyu Li; Xiaojuan Zhang; Guoxiu Liu; Min Gu; Nan Zhang; Jiao Liu; Zhihong Ji; Keao Li; Yongpeng Han; Huaqiang Zhai
Journal:  Biomed Res Int       Date:  2020-03-19       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.